Search Within

Yogesh Tengarai Ganesan

Formats
  1. Journal Article (7)
  2. Meeting Abstract (1)
Groups
  1. Department of Pathology and Laboratory Medicine (7)
  2. GSK Faculty (7)
  3. Human Oncology and Pathogenesis Program (7)
  4. Sloan Kettering Institute Postdocs (6)
  5. Department of Medicine (2)
  6. Solid Tumor Oncology Division (2)

More Groups

People
  1. Emily Cheng (7)
  2. Song Han (4)
  3. Hui-Chen Chen (3)
  4. Shugaku Takeda (3)
  5. Yiyu Dong (3)
  6. Akane Yamauchi (2)

More People

Years
  1. 2021 (1)
  2. 2019 (1)
  3. 2017 (2)
  4. 2016 (2)
  5. 2015 (1)
  6. 2013 (1)
Publications
  1. Analytical Biochemistry (1)
  2. Cancer Cell (1)
  3. Cancer Research (1)
  4. Cell Reports (1)
  5. Molecular Cell (1)
  6. Nature Cell Biology (1)

More Publications

Publishers
  1. Cell Press (3)
  2. Nature Publishing Group (2)
  3. Academic Press, Elsevier Inc (1)
  4. American Association for Cancer Research (1)
  5. American Association for the Advancement of Science (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis
    Journal Article

    Tanaka, K.; Yu, H. A.; Yang, S.; Han, S.; Selcuklu, S. D.; Kim, K.; Ramani, S.; Ganesan, Y. T.; Moyer, A.; Sinha, S.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Enhancing apoptosis to improve the therapy of EGFR-mutant lung cancer
    Meeting Abstract

    Tanaka, K.; Han, S.; Ganesan, Y. T.; Hsieh, J. J.; Cheng, E. H.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • ΔNp63 inhibits oxidative stress-induced cell death, including ferroptosis, and cooperates with the BCL-2 family to promote clonogenic survival
    Journal Article

    Wang, G. X.; Tu, H. C.; Dong, Y.; Skanderup, A. J.; Wang, Y.; Takeda, S.; Ganesan, Y. T.; Han, S.; Liu, H.; Hsieh, J. J.; more...
    Cell Reports (2017)

    Fulltext@MSK | Save
  • Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
    Journal Article

    Inoue-Yamauchi, A.; Jeng, P. S.; Kim, K.; Chen, H. C.; Han, S.; Ganesan, Y. T.; Ishizawa, K.; Jebiwott, S.; Dong, Y.; Pietanza, M. C.; more...
    Nature Communications (2017)

    Fulltext@MSK | Save
  • An autoinhibited dimeric form of BAX regulates the BAX activation pathway
    Journal Article

    Garner, T. P.; Reyna, D. E.; Priyadarshi, A.; Chen, H. C.; Li, S.; Wu, Y.; Ganesan, Y. T.; Malashkevich, V. N.; Almo, S. S.; Cheng, E. H.; more...
    Molecular Cell (2016)

    Fulltext@MSK | Save
  • A sandwich ELISA for the conformation-specific quantification of the activated form of human Bax
    Journal Article

    Teijido, O.; Ganesan, Y. T.; Llanos, R.; Peton, A.; Urtecho, J. B.; Soprani, A.; Villamayor, A.; Antonsson, B.; Manon, S.; Dejean, L.
    Analytical Biochemistry (2016)

    Fulltext@MSK | Save
  • An interconnected hierarchical model of cell death regulation by the BCL-2 family
    Journal Article

    Chen, H. C.; Kanai, M.; Inoue-Yamauchi, A.; Tu, H. C.; Huang, Y.; Ren, D.; Kim, H.; Takeda, S.; Reyna, D. E.; Chan, P. M.; more...
    Nature Cell Biology (2015)

    Fulltext@MSK | Save
  • PUMA and BIM are required for oncogene inactivation-induced apoptosis
    Journal Article

    Bean, G. R.; Ganesan, Y. T.; Dong, Y.; Takeda, S.; Liu, H.; Chan, P. M.; Huang, Y.; Chodosh, L. A.; Zambetti, G. P.; Hsieh, J. J. D.; more...
    Science Signaling (2013)

    Fulltext@MSK | Save